BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tao PY, Zhang ZS, Wang TC, Yu MQ, Xiao YD. A predictive model of incomplete response after transarterial chemoembolization for early or intermediate stage of hepatocellular carcinoma: consideration of hepatic angiographic and cross-sectional imaging. Abdom Radiol (NY) 2021;46:581-9. [PMID: 32761406 DOI: 10.1007/s00261-020-02701-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Xia W, Xu S, Guo Y, Zhao X, Hu H, Zhao Y, Yao Q, Zheng L, Zhang D, Guo C, Fan W, Li H. Plasma arginase-1 as a predictive marker for early transarterial chemoembolization refractoriness in unresectable hepatocellular carcinoma. Front Oncol 2022;12:1014653. [DOI: 10.3389/fonc.2022.1014653] [Reference Citation Analysis]
2 Lee JY, Lee BC, Kim HO, Heo SH, Shin SS, Jeong YY. Liver MRI and clinical findings to predict response after drug eluting bead transarterial chemoembolization in hepatocellular carcinoma. Sci Rep 2021;11:24076. [PMID: 34911966 DOI: 10.1038/s41598-021-01839-6] [Reference Citation Analysis]
3 Yang XY, Deng JB, An TZ, Zhou S, Li JX. Tumor enhancement ratio with unenhanced imaging is an independent prognostic factor for patients with hepatocellular carcinoma after transarterial chemoembolization. J Int Med Res 2021;49:3000605211058367. [PMID: 34812068 DOI: 10.1177/03000605211058367] [Reference Citation Analysis]